Myeloproliferative leukemia protein activation directly induces fibrocyte differentiation to cause myelofibrosis
Authors:
- 3 April 2017
- journal article
- Published by Springer Nature in Leukemia
- Vol. 31 (12) , 2709-2716
Abstract
Myelofibrosis (MF) may be caused by various pathogenic mechanisms such as elevation in circulating cytokine levels, cellular interactions and genetic mutations. However, the underlying mechanism of MF still remains unknown. Recent studies have revealed that fibrocytes, the spindle-shaped fibroblast-like hematopoietic cells, and the thrombopoietin (TPO)/myeloproliferative leukemia protein (MPL; TPO receptor) signaling pathway play a certain role in the development of MF. In the present study, we aimed to investigate the relationship between fibrocytes and MPL activation. We showed that TPO or a TPO receptor agonist directly induces fibrocyte differentiation using murine fibrocyte cell lines and a murine MF model. Conversely, elimination of macrophages expressing MPL by clodronate liposomes reversed the MF phenotype of the murine model, suggesting that fibrocyte differentiation induced by MPL activation contributes to the progression of MF. Furthermore, we revealed that SLAMF7high MPLhigh monocytes in human peripheral blood mononuclear cells were possible fibrocyte precursors and that these cells increased in number in MF patients not treated with ruxolitinib. Our findings confirmed a link between fibrocytes and the TPO/MPL signaling pathway, which could result in a greater understanding of the pathogenesis of MF and lead to the development of novel therapeutic interventions.Keywords
This publication has 38 references indexed in Scilit:
- CS1, a SLAM family receptor involved in immune regulation, is a therapeutic target in multiple myelomaCritical Reviews in Oncology/Hematology, 2013
- Fibrocytes and the pathogenesis of diffuse parenchymal lung diseaseFibrogenesis & Tissue Repair, 2012
- Fibrocytes: emerging effector cells in chronic inflammationNature Reviews Immunology, 2011
- The role of fibrocytes in fibrotic diseases of the lungs and heartFibrogenesis & Tissue Repair, 2011
- Improved serum-free culture conditions for spleen-derived murine fibrocytesJournal of Immunological Methods, 2010
- Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasmsBlood, 2010
- Improved serum-free culture conditions for the differentiation of human and murine fibrocytesJournal of Immunological Methods, 2009
- Identification of Markers that Distinguish Monocyte-Derived Fibrocytes from Monocytes, Macrophages, and FibroblastsPLOS ONE, 2009
- Pivotal contributions of megakaryocytes to the biology of idiopathic myelofibrosisBlood, 2007
- MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid MetaplasiaPLOS Medicine, 2006